Back to Search Start Over

T-15-02: Efficacy, safety and consumption of plasma-derived von Willebrand factor (VWF)/Factor VIII (FVIII) concentrate with 2.4:1 VWF:FVIII ratio for the treatment of von Willebrand Disease: a systematic review.

Authors :
Rugeri, L.
Thomas, W.
Schirner, K.
Heyder, L.
Auerswald, G.
Source :
Hämostaseologie; 2023 Supplement, Vol. 43, pS63-S64, 2p
Publication Year :
2023

Details

Language :
English
ISSN :
07209355
Volume :
43
Database :
Complementary Index
Journal :
Hämostaseologie
Publication Type :
Academic Journal
Accession number :
162983793
Full Text :
https://doi.org/10.1055/s-0042-1760558